Howe Jolanda
Howe Jolanda, SVP, CTRL, reported a transaction classified as exercise at Mirum Pharmaceuticals, Inc. involving 40000.000000 shares for an estimated $250800.00. Reported holdings after the transaction were 41274.000000 shares. A 10b5-1 reference was not detected in the stored filing text.
- Trade date
- Aug 18, 2026
- Filing date
- Aug 19, 2026
How reported position traded is calculated
Calculated only for code-P purchases and code-S sales.
Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.
MIRM price since this filing
Daily closing prices, with the filing date and available return windowsTransaction facts
Stored Form 4 columns with their raw values
- Type
- exercise Code M
- Identifier
- 0001974200-26-000012 Common Stock
- Transaction date
- Aug 18, 2026 Filed Aug 19, 2026, 10:19 PM · 1d delay
- Shares
- 40,000 sh $6.27 per share
- Estimated value
- $250k Computed from shares × price
- Holdings after
- 41,274 sh Direct
Filing signal explanations
Badges describe filing facts only — not predictions.
+10 points
Compact filing score computed from stored Form 4 facts. Version v1.
This filing has a modest positive filing-only score. Treat it as a useful flag for review, not as a buy signal.
How this score is calculated
- direct_ownership+6 points
direct_or_indirect_ownership = D
Direct ownership reports the insider's personal stake. - timely_filing+4 points
reporting_delay_days = 1
Filing reported within two business days of the transaction.
Signed filing-only points, not a probability or expected return. Version v1.
Reported relationships & other filings
Form 4 relationship flags and nearby filing context
SVP, GLOBAL CONTROLLER
- F1
The stock option is fully vested.
0 other transactions
0 recent txs